Lizette Heine

Dynniq (Netherlands)

Papers

1

Total Citations

14

H-Index

1

About

Lizette Heine is a rising researcher at the intersection of artificial intelligence and clinical oncology, with a primary focus on improving cancer diagnostics through advanced imaging techniques. Her work centers on developing and validating AI-driven models that enhance the predictive accuracy of magnetic resonance imaging (MRI) for prostate cancer, particularly in detecting lesion-specific extraprostatic extension (EPE)—a critical factor in treatment planning. Heine’s most cited study, published in 2023, introduces novel machine learning frameworks that outperform conventional radiomics on 3 Tesla multiparametric MRI, addressing a longstanding challenge in non-invasive cancer staging. With 14 citations already, this work underscores her growing influence in the field of medical AI. By integrating deep learning with clinical imaging data, Heine’s contributions promise to refine surgical decision-making and reduce unnecessary interventions. Her research not only advances precision medicine but also sets a foundation for future AI applications in oncology, making her a notable voice in the push toward data-driven, personalized cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
14
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
The Development and External Validation of Artificial Intelligence-Driven MRI-Based Models to Improve Prediction of Lesion-Specific Extraprostatic Extension in Patients with Prostate Cancer
14 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Dynniq (Netherlands)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago